Related Experiment Video
Updated: Jan 1, 2026
10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
36.4K
Genetically Engineered Lung Cancer Cells for Analyzing Epithelial-Mesenchymal Transition
Michał Kiełbus1, Jakub Czapiński1,2, Joanna Kałafut1
1Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.
Cells
|December 19, 2019
Summary
Researchers developed a novel reporter cell line to study cell plasticity, specifically epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET). This tool aids in understanding cancer progression and drug resistance mechanisms.
Area of Science:
- Cellular biology
- Cancer research
- Molecular mechanisms
Background:
- Cell plasticity, including epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET), plays a crucial role in cancer progression and drug resistance.
- Understanding the dynamic nature of EMT/MET is vital for developing effective cancer therapies.
Purpose of the Study:
- To generate and validate a reliable reporter cell line for studying cell plasticity.
- To provide a robust platform for dissecting the molecular mechanisms underlying EMT and MET.
Main Methods:
- Generated a reporter cell line (VRCs) by knocking in a far-red fluorescent protein into the VIMENTIN (VIM) gene in H2170 lung cancer cells.
- Validated the VRCs' ability to exhibit cellular plasticity in response to various stimuli.
Main Results:
- The vimentin reporter cells (VRCs) accurately model EMT and MET processes.
- VRCs demonstrate reliable cellular plasticity, enabling dynamic observation of phenotypic transitions.
Conclusions:
- VRCs serve as a powerful and reliable model for investigating the molecular intricacies of cell plasticity.
- This reporter system offers future potential for in vitro and in vivo drug discovery targeting EMT/MET-driven diseases.
